Making the case for medicines management systems

Pharmaceutical Care Espana

Volumn 3, Issue 4, 2001, Pages 283-306

  Hepler, C D ^a  

^a University of Gainesville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; DRUG MONITORING; DRUG THERAPY; DRUG UTILIZATION; ECONOMIC ASPECT; HEALTH CARE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; MANAGEMENT; MODEL; MORBIDITY; PERFORMANCE; PHARMACEUTICAL CARE; PUBLIC HEALTH; QUALITY OF LIFE; SIDE EFFECT; STANDARD;

EID: 0034877027     PISSN: 11396202     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Societal needs for drugs and drug related services
2. The third wave in pharmaceutical education: The clinical movement
3. Oportunidades y responsabilidades en la Atención Farmacéutica
4. The future of pharmacy: Pharmaceutical care
5. Unresolved issues in the future of pharmacy
6. Preventable drug-related hospital admissions and morbidity in hospitalized patients - A meta-analysis of prevalence reports
7. Errors associated with preventable adverse drug events
8. Outcome analysis of a pharmacist-managed anticoagulation service
9. Economic consequences of two drug-use control systems in a teaching hospital
10. Regulating for outcomes as a system response to the problem of drug related morbidity